Works matching AU Buffart, T E

Results: 7
    1

    Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer—study protocol of the OPTIMA study.

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14500-6
    By:
    • Russ, E.;
    • Ziemons, J.;
    • Hillege, L. E.;
    • van Kuijk, S. M. J.;
    • de Jong, E. M.;
    • Elbers, C.;
    • Deenen, M. J.;
    • Borghuis, L. H.;
    • Böhm, T. M. M.;
    • Kristen, P.;
    • Valk, L. C.;
    • van Hellemond, I. E. G.;
    • Vestjens, H.;
    • Dietvorst, A.;
    • Baars, A.;
    • Goosens, A. N. M.;
    • Vermeulen, L.;
    • Buffart, T. E.;
    • de Vos-Geelen, J.;
    • Penders, J.
    Publication type:
    Article
    2

    KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study.

    Published in:
    British Journal of Cancer, 2014, v. 110, n. 2, p. 546, doi. 10.1038/bjc.2013.824
    By:
    • van Grieken, N C T;
    • Aoyama, T;
    • Chambers, P A;
    • Bottomley, D;
    • Ward, L C;
    • Inam, I;
    • Buffart, T E;
    • Das, K;
    • Lim, T;
    • Pang, B;
    • Zhang, S L;
    • Tan, I B;
    • Carvalho, B;
    • Heideman, D A M;
    • Miyagi, Y;
    • Kameda, Y;
    • Arai, T;
    • Meijer, G A;
    • Tsuburaya, A;
    • Tan, P
    Publication type:
    Article
    3

    KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study.

    Published in:
    British Journal of Cancer, 2013, v. 108, n. 7, p. 1495, doi. 10.1038/bjc.2013.109
    By:
    • van Grieken, N C T;
    • Aoyma, T;
    • Chambers, P A;
    • Bottomley, D;
    • Ward, L C;
    • Inam, I;
    • Buffart, T E;
    • Das, K;
    • Lim, T;
    • Pang, B;
    • Zhang, S L;
    • Tan, I B;
    • Carvalho, B;
    • Heideman, D A M;
    • Miyagi, Y;
    • Kameda, Y;
    • Arai, T;
    • Meijer, G A;
    • Tsuburaya, A;
    • Tan, P
    Publication type:
    Article
    4
    5
    6

    Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT).

    Published in:
    2022
    By:
    • van den Berg, K;
    • Schaap, D P;
    • Voogt, E L K;
    • Buffart, T E;
    • Verheul, H M W;
    • de Groot, J W B;
    • Verhoef, C;
    • Melenhorst, J;
    • Roodhart, J M L;
    • de Wilt, J H W;
    • van Westreenen, H L;
    • Aalbers, A G J;
    • van 't Veer, M;
    • Marijnen, C A M;
    • Vincent, J;
    • Simkens, L H J;
    • Peters, N A J B;
    • Berbée, M;
    • Werter, I M;
    • Snaebjornsson, P
    Publication type:
    journal article
    7